The presentation goal is to demonstrate a new modified technique in processing residual pump blood and thereby reduce the need for blood products and transfusion (22:48 minutes).
Due to small case numbers and the retrospective design of the study, our results neither disprove nor confirm a clinically relevant treatment effect of cytokine adsorption. Results from larger trials, preferably randomized-controlled trials are required to better understand the clinical benefit of cytokine adsorption after ECPR.